Skip to main content
Clinical Trials/NCT03256175
NCT03256175
Completed
N/A

The Effects Of Peri-Percutaneous Coronary Intervention Oxygenation On Myocardial Protection And Cardiovascular Function: A Pilot Study

University of Malaya0 sites40 target enrollmentJuly 1, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
Myocardial Ischemia
Sponsor
University of Malaya
Enrollment
40
Primary Endpoint
The primary objective of this study was to assess the myocardial protection
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Elective percutaneous coronary intervention (PCI) is often associated with myocardial necrosis evidenced by peri-procedural troponin release. This is a surrogate for subsequent cardiovascular events. There is no study on the effect of peri-PCI oxygenation in in myocardial protection and cardiopulmonary fitness outcome. Patients with higher baseline cardiopulmonary fitness will have lower mortality.

This study is to assess the utility of oxygen to reduce ischaemia in patients with significant stable coronary artery disease scheduled for elective PCI. The secondary objective is to evaluate further effect of peri- PCI oxygenation on cardiovascular fitness and autonomic response.

Detailed Description

OBJECTIVE: This study is to assess the utility of oxygen to reduce ischaemia in patients with significant stable coronary artery disease scheduled for elective PCI. The secondary objective is to evaluate further effect of peri- PCI oxygenation on cardiovascular fitness and autonomic response. STUDY DESIGN: Randomized double blinded prospective pilot study SAMPLE SIZE: 30 patients scheduled for elective for PCI randomized to 2 groups, oxygen group ( 15L/min) and air group METHOD: Patient whom fulfil inclusion criteria were recruited and randomized to 2 groups via computer allocation system. The assigned inhaled gas will be delivered via high-flow mask at 15L/min for a minimum of 30 minutes immediately prior to and continued throughout the PCI procedure. Patients were blinded throughout the procedure but the practising cardiologist and staff nurses were not blinded. Routine care continued post PCI. Blood sampling for Troponin I was taken at 6 hours and 24 hours following stent implantation. Patients were discharged one day after the procedure as per current routine practice. Patients were given routine follow up with the cardiac rehabilitation clinic in 4 weeks time post discharge. EST was arranged 6 weeks post procedure PRIMARY OUTCOME MEASURE: Troponin I at 6 and 24 hours SECONDARY OUTCOME MEASURE: METs, Heart Rate Recovery, Chronotropic Index

Registry
clinicaltrials.gov
Start Date
July 1, 2015
End Date
June 30, 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients aged \>18 years
  • Haemodynamically important coronary artery disease (\>70% luminal stenosis angiographically in ≥1 major epicardial coronary artery

Exclusion Criteria

  • Significant chronic airways disease with type-2 respiratory failure precluding safe use of oxygen
  • Coronary stenoses where evidence of plaque instability is evident e.g. rest pain, visual evidence of thrombus, elevation of Troponin T at baseline

Outcomes

Primary Outcomes

The primary objective of this study was to assess the myocardial protection

Time Frame: 6 hours and 24 hours after the procedure

this is done by comparing changes Troponin I at 6 (baseline) to 24 hours between both study arms.

Secondary Outcomes

  • To assess the utility of peri-PCI oxygenation to improve cardiovascular fitness(6 weeks post procedure)
  • To assess the utility of peri-PCI oxygenation to improve autonomic response(6 weeks post procedure)

Similar Trials